Moody’s affirms ‘Aa3’ rating on Baylor Scott & White Health’s bonds

Moody’s Investors Service affirmed the “Aa3” long-term rating and the “Aa3/P-1” short-term rating on Dallas-based Baylor Scott & White Health’s bonds, affecting $2.1 billion of debt.

Advertisement

The long-term rating affirmation is based on a number of factors, including the health system’s position as the largest nonprofit health system in the state, favorable demographics and strong cash flow margins. The short-term rating affirmation is based on the health system’s market access and ability to pay the purchase price of a mandatory tender when due at the end of the mandatory tender window.

The outlook is stable, reflecting Moody’s Investors Service’s favorable opinion of the health system’s ability to respond to challenges quickly and expected improvement in its operating cash flow in fiscal year 2018.

More articles on healthcare finance:
Adeptus Health files for bankruptcy
RCM tip of the day: Seek out a strategic partner, not just a vendor
Acclara Solutions launches as RCM firm

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.